{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:37:20Z","timestamp":1790361440778,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:00:00Z","timestamp":1768608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003336","name":"Bulgarian National Science Fund","doi-asserted-by":"publisher","award":["K\\u041F-06-M61\/6"],"award-info":[{"award-number":["K\\u041F-06-M61\/6"]}],"id":[{"id":"10.13039\/501100003336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Medical Genetics"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.gmg.2026.100094","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T16:51:00Z","timestamp":1768841460000},"page":"100094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6724-4374","authenticated-orcid":false,"given":"Petar Petrov","family":"Donchev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina Yordanova","family":"Vasileva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsvetelina S.","family":"Paunova-Krasteva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetla Trifonova","family":"Danova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gmg.2026.100094_bib1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100094_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gmg.2026.100094_bib3","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1535-6108(02)00096-X","article-title":"Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib","volume":"2","author":"Shah","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gmg.2026.100094_bib6","first-page":"5","article-title":"Exosomes as drug resistance mediators in cancer","volume":"64","author":"Hekmatshoar","year":"2018","journal-title":"Cell Mol. Biol."},{"key":"10.1016\/j.gmg.2026.100094_bib7","first-page":"2127","article-title":"Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to imatinib","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.gmg.2026.100094_bib8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0145-2126(94)90075-2","article-title":"Detection of BCR-ABL mutations in patients with CML treated with imatinib","volume":"18","author":"Thomas","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.gmg.2026.100094_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3390\/cancers14040885","article-title":"Exosomal miRNAs in cancer","volume":"14","author":"O\u2019Brien","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.gmg.2026.100094_bib10","first-page":"1231","article-title":"Cannabidiol as potential anticancer agent","volume":"168","author":"Massi","year":"2013","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.gmg.2026.100094_bib11","first-page":"290","article-title":"Cannabidiol enhances the activity of chemotherapy","volume":"14","author":"Scott","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.gmg.2026.100094_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1535-7163.MCT-10-1100","article-title":"Cannabidiol induces programmed cell death in breast cancer cells","volume":"10","author":"Shrivastava","year":"2011","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.gmg.2026.100094_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3389\/fphar.2018.00889","article-title":"Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle release in cancer","volume":"9","author":"Kosgodage","year":"2018","journal-title":"Front. Pharm."},{"key":"10.1016\/j.gmg.2026.100094_bib14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/cells9061450","article-title":"Exosomal miRNAs as biomarkers in leukemia","volume":"9","author":"Santos","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.gmg.2026.100094_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3389\/fonc.2020.00472","article-title":"Exosomal miRNAs in cancer drug resistance","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib16","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gmg.2026.100094_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.gmg.2026.100094_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semcancer.2021.03.014","article-title":"miRNAs mediated drug resistance in hematological malignancies","volume":"83","author":"Da Silva","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.gmg.2026.100094_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.848199","article-title":"A systematic review of candidate miRNAs, their targeted genes and pathways in chronic myeloid leukemia \u2013 an integrated bioinformatical analysis","volume":"12","author":"Elias","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib20","first-page":"3505","article-title":"Exosomal miRNAs in leukemia progression","volume":"40","author":"Min","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.gmg.2026.100094_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3892\/ijo.2020.5163","article-title":"Exosomal miRNAs in hematological malignancies","volume":"58","author":"Hrdinova","year":"2021","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib22","article-title":"Cannabidiol and leukemia drug resistance, Naunyn-Schmiedeberg\u2019s","author":"Naqvi","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.gmg.2026.100094_bib23","article-title":"Exosomal miRNAs in CML resistance","volume":"12","author":"Zhao","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib24","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.3390\/cancers16233948","article-title":"Potential use of exosomal non-coding microRNAs in leukemia therapy: a systematic review","volume":"16","author":"Gil-Kulik","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gmg.2026.100094_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0331479","article-title":"Exosomal miRNA expression profiling in patients with imatinib-resistant chronic myeloid leukemia: A pilot study","volume":"20","author":"Navakanitworakul","year":"2025","journal-title":"PLoS ONE"},{"key":"10.1016\/j.gmg.2026.100094_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40164-020-00183-1","volume":"9","author":"Klumper","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib27","first-page":"1","article-title":"Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review)","volume":"51","author":"Shao","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-020-00920-3","article-title":"High mobility group box 1 (HMGB1): A pivotal regulator of hematopoietic malignancies","volume":"13","author":"Yuan","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1515\/biol-2021-0022","article-title":"miR-299-3p suppresses cell progression and induces apoptosis by downregulating PAX3 in gastric cancer","volume":"16","author":"Wang","year":"2021","journal-title":"Open Life Sci."},{"key":"10.1016\/j.gmg.2026.100094_bib30","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.3390\/ijms23179643","article-title":"Downregulation of miR-99b-5p and upregulation of nuclear mTOR cooperatively promotes tumor aggressiveness and drug resistance in African American prostate cancer","volume":"23","author":"Gujrati","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gmg.2026.100094_bib31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/CMAR.S183328","article-title":"Suppression of miR-21-3p enhances TRAIL mediated apoptosis in liver cancer stem cells by suppressing PI3K\/Akt\/Bad cascade via regulating PTEN","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.gmg.2026.100094_bib32","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12032-025-02900-4","article-title":"The emerging role of miR-362 in cancer: Expression and function across different cancer types","volume":"42","author":"Younis","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13046-025-03355-1","article-title":"CircPVT1 weakens miR-33a-5p unleashing the c-MYC\/GLS1 metabolic axis in breast cancer","volume":"44","author":"Palcau","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gmg.2026.100094_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/jca.48769","article-title":"Emerging roles of miR-133a in human cancers","volume":"12","author":"Hua","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.gmg.2026.100094_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003784","article-title":"MicroRNA-5010-5p ameliorates high glucose-induced inflammation in renal tubular epithelial cells by modulating PPP2R2D","volume":"12","author":"Choi","year":"2024","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.gmg.2026.100094_bib36","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.3390\/biomedicines13071604","article-title":"Diagnostic and prognostic roles of miR-155 and miR-3173 in breast and ovarian cancer: Implications for early detection and personalized treatment","volume":"13","author":"Altrawy","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.gmg.2026.100094_bib37","first-page":"145","article-title":"miR-1226-5p contributes to radioresistance in colorectal cancer by activating M2 macrophages through suppression of IRF1","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13027-024-00628-w","article-title":"miR-3191 promotes the proliferation and metastasis of hepatocellular carcinoma via regulating PAK6","volume":"19","author":"Xie","year":"2024","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.gmg.2026.100094_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/hemato6030030","article-title":"miR-429 acts as a tumor suppressor in multiple myeloma by regulating cell proliferation","volume":"6","author":"Abdelkarim","year":"2025","journal-title":"Hemato"},{"key":"10.1016\/j.gmg.2026.100094_bib40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3727\/096504020X16037933185170","article-title":"MicroRNA-548m suppresses cell migration and invasion by targeting aryl hydrocarbon receptor in breast cancer cells","volume":"28","author":"Nor","year":"2021","journal-title":"Oncol. Res."},{"key":"10.1016\/j.gmg.2026.100094_bib41","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.1038\/s41598-019-42221-x","article-title":"MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer","volume":"9","author":"Biamonte","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gmg.2026.100094_bib42","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1186\/s12967-023-04649-8","article-title":"The important role of miR-1-3p in cancers","volume":"21","author":"Dai","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib43","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/jca.48769","article-title":"Emerging roles of miR-133a in human cancers","volume":"12","author":"Hua","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.gmg.2026.100094_bib44","first-page":"372","article-title":"Pivotal role of microRNA-33 in metabolic syndrome: A systematic review","volume":"9","author":"Gharipour","year":"2013","journal-title":"ARYA Atheroscler."},{"key":"10.1016\/j.gmg.2026.100094_bib45","first-page":"59610","article-title":"MiR-4435 is a UQCRB-related circulating miRNA in human colorectal cancer","volume":"10","author":"Hong","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.gmg.2026.100094_bib46","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/cdd.2014.176","article-title":"Transformer 2\u03b2 and miR-204 regulate apoptosis through competitive binding to the 3\u2032UTR of BCL2 mRNA","volume":"22","author":"Kuwano","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.gmg.2026.100094_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105965","article-title":"Cell-specific tumor suppressor effect of hsa-miR-1226-3p through downregulation of HER2, PIK3R2, and AKT1 genes","volume":"134","author":"Mohamadzade","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.gmg.2026.100094_bib48","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1080\/21655979.2022.2051266","article-title":"Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K\/Akt signaling pathway and induced apoptosis in hypopharyngeal squamous cell carcinoma","volume":"13","author":"Gao","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.gmg.2026.100094_bib49","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3389\/fcell.2020.00540","article-title":"MicroRNA-138-5p suppresses non-small cell lung cancer cells by targeting PD-L1\/PD-1 to regulate tumor microenvironment","volume":"8","author":"Song","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.gmg.2026.100094_bib50","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1177\/15353702211066908","article-title":"MicroRNA regulation of BAG3","volume":"247","author":"Singh","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib51","article-title":"A comprehensive review on miR-153: Mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells","volume":"12","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.gmg.2026.100094_bib52","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.21037\/atm-20-4469","article-title":"MiR-3121-3p promotes tumor invasion and metastasis by suppressing Rap1GAP in papillary thyroid cancer in vitro","volume":"8","author":"Xu","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.gmg.2026.100094_bib53","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/s13046-020-01705-9","article-title":"MiR-103a-3p promotes tumour glycolysis in colorectal cancer via Hippo\/YAP1\/HIF1A axis","volume":"39","author":"Sun","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.gmg.2026.100094_bib54","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.3390\/ijms241310777","article-title":"Effects of miR-33 deficiency on metabolic and cardiovascular diseases: Implications for therapeutic intervention","volume":"24","author":"Ortega","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940426000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:38:49Z","timestamp":1778931529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2699940426000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2699940426000020"],"URL":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100094","relation":{},"ISSN":["2699-9404"],"issn-type":[{"value":"2699-9404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol modulates exosomal miRNA networks to enhance Imatinib mesylate response in chronic myelogenous leukemia","name":"articletitle","label":"Article Title"},{"value":"Global Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gmg.2026.100094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100094"}}